SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F/A - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: [Amend]
SEC Accession No. 0001193125-21-140825
Filing Date
2021-04-29
Accepted
2021-04-29 17:16:30
Documents
135
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 40-F/A d153505d40fa.htm 40-F/A 25118
  Complete submission text file 0001193125-21-140825.txt   15439838

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT crlbf-20201231.xml EX-101.INS 4962109
3 XBRL TAXONOMY EXTENSION SCHEMA crlbf-20201231.xsd EX-101.SCH 208616
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crlbf-20201231_cal.xml EX-101.CAL 81964
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crlbf-20201231_def.xml EX-101.DEF 659683
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE crlbf-20201231_lab.xml EX-101.LAB 1114981
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crlbf-20201231_pre.xml EX-101.PRE 913468
Mailing Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654
Business Address 400 W ERIE ST SUITE 110 CHICAGO IL 60654 (312) 929-0993
Cresco Labs Inc. (Filer) CIK: 0001832928 (see all company filings)

IRS No.: 981505364 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 40-F/A | Act: 34 | File No.: 000-56241 | Film No.: 21872097
SIC: 2833 Medicinal Chemicals & Botanical Products